- Home
- GOVX vs MBOT Comparison
GOVX vs MBOT Comparison
Compare GOVX & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOVX
- MBOT
- Stock Information
- Founded
- GOVX 2001
- MBOT 2010
- Country
- GOVX United States
- MBOT United States
- Employees
- GOVX N/A
- MBOT N/A
- Industry
- GOVX Biotechnology: Pharmaceutical Preparations
- MBOT Medical/Dental Instruments
- Sector
- GOVX Health Care
- MBOT Health Care
- Exchange
- GOVX Nasdaq
- MBOT Nasdaq
- Market Cap
- GOVX 17.4M
- MBOT 184.8M
- IPO Year
- GOVX N/A
- MBOT N/A
- Fundamental
- Price
- GOVX $0.68
- MBOT $3.32
- Analyst Decision
- GOVX Strong Buy
- MBOT Strong Buy
- Analyst Count
- GOVX 3
- MBOT 1
- Target Price
- GOVX $10.67
- MBOT $12.00
- AVG Volume (30 Days)
- GOVX 591.0K
- MBOT 7.2M
- Earning Date
- GOVX 11-11-2025
- MBOT 11-12-2025
- Dividend Yield
- GOVX N/A
- MBOT N/A
- EPS Growth
- GOVX N/A
- MBOT N/A
- EPS
- GOVX N/A
- MBOT N/A
- Revenue
- GOVX $6,143,044.00
- MBOT N/A
- Revenue This Year
- GOVX N/A
- MBOT N/A
- Revenue Next Year
- GOVX N/A
- MBOT $728.02
- P/E Ratio
- GOVX N/A
- MBOT N/A
- Revenue Growth
- GOVX 1943.07
- MBOT N/A
- 52 Week Low
- GOVX $0.43
- MBOT $0.85
- 52 Week High
- GOVX $3.88
- MBOT $4.67
- Technical
- Relative Strength Index (RSI)
- GOVX 41.05
- MBOT 46.89
- Support Level
- GOVX $0.67
- MBOT $3.25
- Resistance Level
- GOVX $0.73
- MBOT $4.25
- Average True Range (ATR)
- GOVX 0.04
- MBOT 0.42
- MACD
- GOVX -0.00
- MBOT -0.09
- Stochastic Oscillator
- GOVX 24.14
- MBOT 10.60
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.
About MBOT Microbot Medical Inc.
Microbot Medical Inc is a clinical-stage medical device company specializing in the research, design and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. It is focused on leveraging its robotic technologies to redefine surgical robotics while improving surgical outcomes for patients. Using its LIBERTY technological platform, the company is developing the first-ever fully disposable robot for various endovascular interventional procedures.